Skip to main content


Log in

Medication Guide Reading Behaviors and Attitudes Among Subjects With Migraine, Asthma, or COPD

  • Policy: Original Research
  • Published:
Therapeutic Innovation & Regulatory Science Aims and scope Submit manuscript



This cross-sectional survey describes attitudes and reading behaviors toward medication guides among 785 subjects with migraine, asthma, or COPD who reported recent use of Treximet (sumatriptan/naproxen sodium) or Advair (fluticasone propionate/salmeterol).


The survey demonstrated that the majority (82%) of subjects had read their medication guide, but most read it exactly once and did not read it thoroughly. Patients did not read medication guides with each refill, with the most frequent reasons being that they did not expect the information to have changed and that a doctor would tell them what they needed to know. Factors significantly associated with patients hypothetically being more likely to read medication guides associated with their new prescription included increasing age, simplification to format and content of the medication guide, and where subjects typically received their medication safety information. Patients reported acquiring medication safety from doctors or pharmacists more frequently than from medication guides.


The results provide insights into potential revisions to the medication guides that may improve reading behaviors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others


  1. US Food and Drug Administration. Guidance. Useful Written Consumer Information. 2006. Available at Accessed April 22, 2014.

  2. US Department of Health and Human Services. Medication Guides for Prescription Drug Products. Title 21: Code of Federal Regulations 2004;208:115–116.

    Google Scholar 

  3. US Food and Drug Administration. Medication Guides. 2012. Available at Accessed April 22, 2014.

  4. Raynor DK, Blenkinsopp A, Knapp P, et al. A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. Health Technol Assess. 2007;11:1–160.

    Article  Google Scholar 

  5. Svarstad BL, Mount JK. Evaluation of Written Prescription Information Provided in Community Pharmacies. Final report to the U.S. Department of Health and Human Services and the Food and Drug Administration. 2001. Available at Accessed April 22, 2014.

  6. Kimberlin CL, Winterstein AG. Expert and Consumer Evaluation of Consumer Medication Information—2008—US Food and Drug Administration. Available at Accessed April 22, 2014.

  7. Aker J, Beck M, Papay JI, et al. Consumers better understand and prefer simplified written drug information: an evaluation of 2 novel formats versus the current CMI. Therapeutic Innovation & Regulatory Science. 2013;47:125–132.

    Article  Google Scholar 

  8. Wolf MS, Davis TC, Shrank WH, Neuberger M, Parker RM. A critical review of FDA-approved medication guides. Patient Educ Couns. 2006;62:316–322.

    Article  Google Scholar 

  9. US Food and Drug Administration. Public Hearing on the Use of Medication Guides to Distribute Drug Risk Information. Available at Accessed April 22, 2014.

  10. Wolf MS, King J, Wilson EA, et al. Usability of FDA-approved medication guides. J Gen Intern Med. 2012;27:1714–1720.

    Article  Google Scholar 

  11. Shiffman S, Gerlach KK, Sembower MA, Rohay JM. Consumer understanding of prescription drug information: an illustration using an antidepressant medication. Ann Pharmacother. 2011;45:452–458.

    Article  Google Scholar 

  12. Zapata LB, Steenland MW, Brahmi D, Marchbanks PA, Curtis KM. Patient understanding of oral contraceptive pill instructions related to missed pills: a systematic review. Contraception. 2013;87:674–684.

    Article  Google Scholar 

  13. Allen LaPointe NM, Pappas P, Deverka P, Anstrom KJ. Patient receipt and understanding of written information provided with isotretinoin and estrogen prescriptions. J Gen Intern Med. 2007;22:98–101.

    Article  Google Scholar 

  14. Shrank WH, Avorn J. Educating patients about their medications: the potential and limitations of written drug information. Health Aff (Millwood). 2007;26:731–740.

    Article  Google Scholar 

  15. US Food and Drug Administration. Minutes of the Risk Communication Advisory Committee, Thursday, February 26, and Friday, February 27, 2009. Available at Accessed April 22, 2014.

  16. US Food and Drug Administration. Public Hearing on Development and Distribution of Patient Medication Information for Prescription Drugs. Silver Spring, MD, September 27–28, 2010. Available at Accessed April 22, 2014.

  17. The Brookings Institution. The Science of Communicating Medication Information to Consumers. An Engelgerg Center for Healthcare Reform Event. Washington, DC, July 21, 2010.

  18. US Food and Drug Administration. Approved Risk Evaluation and Mitigation Strategies (REMS). 2012. Available at Accessed April 22, 2014.

  19. Curtis LM, Wolf MS, Weiss KB, Grammer LC. The impact of health literacy and socioeconomic status on asthma disparities. J Asthma. 2012;49:178–183.

    Article  Google Scholar 

  20. DiSantostefano RL, Beck M, Yeakey AM, Raphiou I, Stempel DA. Patient comprehension of medication guides for asthma and chronic obstructive pulmonary disease medications. Therapeutic Innovation & Regulatory Science. 2014;2168479014524407.

  21. Wolf MS, Davis TC, Bass PF, et al. Improving prescription drug warnings to promote patient comprehension. Arch Intern Med. 2010;170:50–56. Erratum in: Arch Intern Med. 2010;170:608.

    Article  Google Scholar 

  22. Papay JI, Fritz D, Cantu T, Ellis M, Debussey S. Assessment of a simplified format of written patient prescription drug information. Drug Inf J. 2010;44:375–391.

    Article  Google Scholar 

  23. Nathan JP, Zerilli T, Cicero LA, Rosenberg JM. Patients’ use and perception of medication information leaflets. Ann Pharmacother. 2007;41:777–782.

    Article  Google Scholar 

  24. Carpenter DM, DeVellis RF, Hogan SL, et al. Use and perceived credibility of medication information sources for patients with a rare illness: differences by gender. J Health Commun. 2011;16:629–642.

    Article  Google Scholar 

  25. DeLorme DE, Huh J, Reid LN. Source selection in prescription drug information seeking and influencing factors: applying the comprehensive model of information seeking in an American context. J Health Commun. 2011;16:766–787.

    Article  Google Scholar 

  26. Walsh TM, Volsko TA. Readability assessment of Internet-based consumer health information. Respir Care. 2008;53:1310–1315.

    PubMed  Google Scholar 

  27. Risoldi Cochrane Z, Gregory P, Wilson A. Readability of consumer health information on the Internet: A comparison of U.S. government-funded and commercially funded websites. J Health Comm. 2012;17:1003–1010.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Kristen B. Bibeau PhD, MSPH.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bibeau, K.B., DiSantostefano, R.L. & Hinds, D. Medication Guide Reading Behaviors and Attitudes Among Subjects With Migraine, Asthma, or COPD. Ther Innov Regul Sci 49, 377–386 (2015).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: